Next-generation sequencing player ArcherDX and precision medicine company HeliTec are teaming up to develop NGS-based cancer diagnostics in China. The pair will work on NGS-based tech and aim to get ...
BOULDER, Colo.--(BUSINESS WIRE)--ArcherDX, Inc. today announced an agreement to develop next-generation sequencing (NGS)-based in vitro diagnostic (IVD) tests with Illumina, Inc. (NASDAQ: ILMN). Under ...
ArcherDX is bringing it up a notch through a new collaboration with Ayala Pharmaceuticals, a clinical stage precision oncology company. In the agreement, Denver, CO-based ArcherDX will develop ...
ArcherDX has closed on a $60 million financing round to support its companion diagnostic program spanning solid and blood tumors, as well as circulating tumor DNA tests. The Boulder, Colorado-based ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from Archer Materials ( (AU:AXE ...
BOULDER, Colo., Oct. 3, 2018 /PRNewswire/ -- ArcherDX, a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine and ...
BOULDER, Colo., Dec. 3, 2019 /PRNewswire/ -- ArcherDX, Inc., a growth-stage molecular diagnostics company dedicated to developing breakthrough solutions that advance personalized genomic medicine, ...
Enzymatics, a Beverly, Mass.-based diagnostics company, has acquired Boulder startup ArcherDx Inc. in a deal with a potential value of about $50 million, officials announced Friday. ArcherDx, formed ...
Horizon Discovery Group plc and ArcherDX, Inc. have announced that they have signed an Original Equipment Manufacture (OEM) agreement that will see Horizon’s Reference Materials supplied as a ...
Archer Materials ( (AU:AXE) ) has issued an update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results